{
    "eid": "2-s2.0-85106907639",
    "title": "Genetic determinants in hla and cytochrome p450 genes in the risk of aromatic antiepileptic-induced severe cutaneous adverse reactions",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (miscellaneous)",
            "@code": "2701",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Antiepileptics",
        "Cutaneous adverse drug reaction",
        "CYP450 enzymes",
        "Genetic polymorphism",
        "HLA",
        "SCAR"
    ],
    "authors": [
        "Ali Fadhel Ahmed",
        "Chonlaphat Sukasem",
        "Majeed Arsheed Sabbah",
        "Nur Fadhlina Musa",
        "Dzul Azri Mohamed Noor",
        "Nur Aizati Athirah Daud"
    ],
    "citedby-count": 4,
    "ref-count": 144,
    "ref-list": [
        "Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies",
        "Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients",
        "Delayed hypersensitivity to antiepileptic drugs in children",
        "Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Me-ta-analysis",
        "Severe cutaneous adverse reactions to drugs",
        "Medication Use and the Risk of Stevens\u2013Johnson Syndrome or Toxic Epidermal Necrolysis",
        "Toxic epidermal necrolysis in the absence of circulating T cells: A possi-ble role for resident memory T cells",
        "Genetic association of co\u2013trimoxazole\u2013induced se-vere cutaneous adverse reactions is phenotype\u2013specific: HLA class I genotypes and haplotypes",
        "Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions",
        "Phenobarbital\u2013induced severe cutaneous ad-verse drug reactions are associated with CYP2C19* 2 in Thai children",
        "Implementation of Genetic Screening to Prevent Severe Cutaneous Ad-verse Drug Reactions Is Crucial\u2014Rebuttal from the Devil\u2019s Antagonist",
        "Epidemiology and risk factors for drug allergy",
        "Antiepileptic drug-induced hypersensitivity syndrome reactions",
        "Anticonvulsant hypersensitivity syn-drome associated with carbamazepine administration: Case series",
        "A Systematic Review on Lamotrigine Induced Skin Rashes",
        "The Spectrum of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Clinical Classification",
        "Severe cutaneous adverse reactions to drugs",
        "HLA and pharmacogenetics of drug hypersensitivity",
        "Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome",
        "Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis",
        "Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis",
        "UK guidelines for the management of Stevens\u2013Johnson syndrome/toxic epidermal necrolysis in adults 2016",
        "Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens\u2013Johnson syndrome: Our current understanding",
        "Stevens-Johnson Syndrome: A Diagnostic Challenge in the Absence of Skin Lesions",
        "Severe cutaneous adverse drug reactions: A review on epidemiology, etiology, clinical manifestation and pathogenesis",
        "Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist?",
        "Chronic obstructive pulmonary disease phenotypes: The future of COPD",
        "ALDEN, an algorithm for assessment of drug causal-ity in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: Comparison with case\u2013control analysis",
        "Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme",
        "Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France",
        "A Multicenter Review of Toxic Epidermal Necrolysis Treated in U.S. Burn Centers at the End of the Twentieth Century",
        "Genomics of adverse drug reactions",
        "Antigenic Peptide Loading into Major Histocompatibility Complex Class I Is Driven by the Substrate N-Terminus",
        "A method for estimating the probability of adverse drug reactions",
        "Association of HLA-B* 1502 allele and carbamazepine-induced severe adverse cutaneous drug reaction among Asians, a review",
        "Mechanisms of MHC class I-restricted antigen processing and cross-presentation",
        "The danger hypothesis\u2014potential role in idiosyncratic drug reactions",
        "Human leukocyte antigen (HLA) pharmacogenomic tests: Potential and pitfalls",
        "Adverse drug reactions in older adults: A narrative review of the literature",
        "Drug Hypersensitivity and Human Leukocyte Antigens of the Major Histocompatibility Complex",
        "Adverse drug reactions: Definitions, diagnosis, and management",
        "HLA: A pharmacogenomics success story",
        "Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions",
        "IPD-IMGT/HLA Database",
        "The IPD and IMGT/HLA database: Allele variant databases",
        "Significant variation between SNP-based HLA imputations in diverse populations: The last mile is the hardest",
        "Challenging views on the peopling history of East Asia: The story according to HLA markers",
        "Balancing selection and heterogeneity across the classical human leukocyte antigen loci: A meta-analytic review of 497 population studies",
        "Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population",
        "Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics",
        "HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans",
        "Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population",
        "Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans",
        "HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: An international study and meta-analysis",
        "Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions",
        "A marker for Stevens\u2013Johnson syndrome",
        "Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population",
        "HLA-B* 1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese",
        "Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model",
        "Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization",
        "HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients",
        "HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens\u2013Johnson syndrome and toxic epidermal necrolysis",
        "High Detection Rate of Copy Number Variations Using Capture Sequencing Data: A Retrospective Study",
        "HLA\u2013B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese",
        "Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population",
        "Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population",
        "Association ofHLA-B*1502allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: A meta-analysis",
        "Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B* 13: 01 allele in the Thai population",
        "6-Locus HLA allele and haplotype frequencies in a population of 1075 Russians from Karelia",
        "Determination of HLA-A,-C,-B,-DRB1 allele and haplotype frequency in Japanese population based on family study",
        "HLA\u2013A,\u2013B and\u2013DRB 1 polymorphism in K oreans defined by sequence\u2013based typing of 4128 cord blood units",
        "Distribution of human leucocyte antigen\u2013A,\u2013B and\u2013DR alleles and haplotypes at high resolution in the population from Jiangsu province of China",
        "HLA-A,-B,-DRB1,-DQA1, and-DQB1 polymorphism in thais",
        "Distribution of HLA-B alleles in nasopharyngeal carcinoma patients and normal controls in Thailand",
        "The distribution of human leukocyte antigen-A,-B, and-DRB1 alleles and haplotypes based on high-resolution genotyping of 167 families from Jiangsu Province, China",
        "Distributions of HLA class I alleles and haplotypes in Northern Han Chinese",
        "Distribution of HLA-A,-B,-Cw, and-DRB1 alleles and haplotypes in an isolated Han population in Southwest China",
        "HLA class I and II alleles and haplotypes in ethnic Northeast Thais",
        "HLA-A,-B,-C,-DRB1 and-DQB1 alleles and haplotypes in 951 Southeast Asia Malays from Peninsular Malaysia",
        "Malayalam speaking population from South India: Common five-locus haplotypes in Malayalam speaking population",
        "HLA-A,-B,-C,-DRB1 and-DQB1 alleles and haplotypes in the Kinh population in Vietnam",
        "Association of HLA-A,-B, and-DRB1 with pulmonary tuberculosis in western Javanese Indonesia",
        "High-throughput DNA typing of HLA-A,-B,-C, and-DRB1 loci by a PCR\u2013SSOP\u2013Luminex method in the Japanese population",
        "HLA class II alleles in Ainu living in Hidaka district, Hokkaido, northern Japan",
        "American Academy of Neurology Society; European Federation of Neurological Society. AAN-EFNS guidelines on trigeminal neuralgia management",
        "The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: An unblinded randomised controlled trial",
        "HLA Association with Drug-Induced Adverse Reactions",
        "HLA-B* 1502 and carbamazepine induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Indonesia",
        "HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review",
        "Developing pharmacogenetic screening methods for an emergent country: Vietnam",
        "HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: Pooled-data and in silico analysis",
        "Association of HLA-B* 1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians",
        "Association between HLA-B*1502 Allele and Antiepileptic Drug-Induced Cutaneous Reactions in Han Chinese",
        "HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions",
        "Association between HLA-B alleles and carbamazepine-induced macu-lopapular exanthema and severe cutaneous reactions in Thai patients",
        "Relationship between the HLA-B* 1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic re-view and meta-analysis",
        "Carbamazepine, HLA-B* 1502 and risk of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations",
        "Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland",
        "Genetics of Immune-Mediated Adverse Drug Reactions: A Comprehensive and Clinical Review",
        "HLA-B* 1502 screening: Time to clinical practice",
        "Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population",
        "Genome-wide mapping for clinically relevant predictors of lamotrigine-and phenytoin-induced hypersensitivity reactions",
        "Association of HLA-A and HLA-B alleles with lamotrigi-ne-induced cutaneous adverse drug reactions in the Thai population",
        "Drug-induced skin adverse reactions: The role of pharmacogenomics in their pre-vention",
        "A European study of HLA-B in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs",
        "High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients",
        "Clinical features of and genetic predisposition to drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients\u2014investigating the relation between the HLA-B* 4403 allele and lamotrigine",
        "Anticonvulsant hypersensitivity syndrome: An update",
        "Severe cutaneous adverse reactions to antiepileptic drugs in Asians",
        "Specific HLA types are associated with antiepileptic drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Japanese subjects",
        "HLA-B*1502 allele is associated with a cross-reactivity pattern of cutaneous adverse reactions to antiepileptic drugs",
        "Investigate the Strategy of Using Pharmacogenetics and Pharmacometabonomics to the Personalization of Ticagrelor Antiplatelet Therapy",
        "Clinical importance of the cytochromes P450",
        "The Role of Genetic Polymor-phism and Other Factors on Clopidogrel Re-sistance (CR) in an Asian Population with Coronary Heart Disease (CHD)",
        "PharmVar Steering Committee. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the human cytochrome P450 (CYP) allele nomenclature database",
        "Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications",
        "Cytochrome P4502C9: An enzyme of major importance in human drug metabolism",
        "Genetic polymorphism of the CYP2C subfamily and its effect on the pharma-cokinetics of phenytoin in Japanese patients with epilepsy",
        "Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin",
        "The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement",
        "Update on the genetic polymorphisms of drug-metabolizing enzymes in an-tiepileptic drug therapy",
        "Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China",
        "Effect ofCYP3A5*3genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients",
        "Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes",
        "Effect of CYP3A5*3 on carbamazepine pharmacokinetics in Japanese patients with epilepsy",
        "Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions",
        "Cytochrome P450 2C9 gene polymorphism in phenytoin induced gingival enlargement: A case report",
        "CYP2C9 polymorphisms in epilepsy: Influence on phenytoin treatment",
        "Role of CYP2C9 polymorphism in phenytoin-related metabolic abnormalities and subclinical atherosclerosis in young adult epileptic patients",
        "Frequency of cytochrome P450 2C9 (CYP2C9) alleles in three ethnic groups in Malaysia",
        "The clinical impact of cytochrome P450 polymorphisms on anti-epileptic drug therapy",
        "Population Estimation of the Effects of Cytochrome P450 2C9 and 2C19 Polymorphisms on Phenobarbital Clearance in Japanese",
        "Building pharmacogenetics into a pharmacovigilance program in Singapore: Using serious skin rash as a pilot study",
        "SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation",
        "Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan",
        "Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacoge-netic Dosing Guidelines?"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Minden",
            "@id": "60120552",
            "affilname": "School of Pharmaceutical Sciences, Universiti Sains Malaysia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60120552",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Baghdad",
            "@id": "60071152",
            "affilname": "Al-Nahrain University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071152",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kubang Kerian",
            "@id": "60002512",
            "affilname": "School of Medical Sciences, Universiti Sains Malaysia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002512",
            "affiliation-country": "Malaysia"
        }
    ],
    "funding": [
        "International Research Network-The Thailand Research Fund",
        "Universiti Sains Malaysia"
    ]
}